OXiGENE is a biopharmaceutical company whose mission is finding and developing new and improved therapeutics that can deliver significant medical benefits to patients with cancer and sight-threatening eye diseases and conditions.
Tuesday, March 4, 2014
OXiGENE Announces Full Year 2013 Earnings Conference Call and Webcast
Wednesday, February 12, 2014
OXiGENE, Inc. Announces $12 Million Public Offering